Antithymocyte globulin therapy in chronic lung allograft dysfunction

Antithymocyte globulin therapy in chronic lung allograft dysfunction

IntroductionLung transplantation has seen strides in survival over the past few decades, though long-term survival remains poor. Chronic lung allograft dysfunction (CLAD) is a leading cause of graft failure and mortality beyond the first year. Anti-thymocyte globulin (ATG) is commonly used for treat...

Full description

Saved in:
Bibliographic Details
Main Authors: Akhilesh Ajay Padhye, Danielle Guffey, Andres Leon-Pena, Justin Segraves, Ramiro Fernandez, Gabriel Loor, Puneet Garcha, Tianshi David Wu, Gloria Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Transplantation
Subjects:
chronic lung allograft dysfunction
anti-thymocyte globulin
lung function
FEV1
CLAD
ATG
Online Access:https://www.frontiersin.org/articles/10.3389/frtra.2025.1607678/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/frtra.2025.1607678/full

Similar Items